Primary central nervous system lymphoma: A curable brain tumor

Journal of Clinical Oncology

Volumn 21, Issue 24, 2003, Pages 4471-4473

  DeAngelis, Lisa M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE; VINDESINE;

AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG MEGADOSE; EDITORIAL; HUMAN; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; TUMOR BIOPSY; BRAIN TUMOR; LYMPHOMA; NOTE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; HUMANS; LYMPHOMA;

EID: 1542543439     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.08.900     Document Type: Editorial

References (19)

1. Lai R, Rosenblum MC, DeAngelis LM: Primary CNS lymphoma: A whole brain disease? Neurology 59:1557-1562, 2002
2. Abrey LE, DeAngelis LM, Yahalom J: Long term survival in primary central nervous system lymphoma. J Clin Oncol 16:859-863, 1998
3. Abrey LE, Yahalom J, DeAngelis LM: Treatment for primary CNS lymphoma: The next step. J Clin Oncol 18:3144-3150, 2000
4. DeAngelis LM, Seiferheld W, Schold CS, et al: Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation therapy oncology group study 93-10. J Clin Oncol 20:4643-4648, 2002
5. Batchelor T, Carson K, O'Neill A, et al: Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: A report of NABTT 96-07. J Clin Oncol 21:1044-1049, 2003
6. Mead GM, Bleehen NM, Gregor A: A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma. Cancer 89:1359-1370, 2000
7. Poortmans P, Kluin-Nelemans HC, Reiche HH, et al: European Organization for Research and Treatment of Cancer Lymphoma Group phase II trial 20962 evaluating high-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary CNS lymphoma. J Clin Oncol 21:4483-4489, 2003
8. Pels H, Schmidt-Wolf IGH, Glasmacher A, et al: Primary central nervous system lymphoma: Results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 21:4489-4495, 2003
9. O'Neill BP, O'Fallon JR, Earle JD, et al: Primary central nervous system non-Hodgkin's lymphoma: Survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys 33:663-673, 1995
10. Schultz C, Scott C, Sherman W, et al: Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphoma: Initial report of Radiation Therapy Oncology Group protocol 88-06. J Clin Oncol 14:556-564, 1996
11. Herrlinger U, Schabet M, Brugger W, et al: German cancer society neuro-oncology working group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. Ann Neurol 51:247-252, 2002
12. Gorlick R, Goker E, Trippett T, et al: Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression. Blood 89:1013-1018, 1997
13. Cheok MH, Yang W, Pui C-H, et al: Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nat Genet 34:85-90, 2003
14. Ferreri AJ, Reni M, Dell'Oro S, et al: Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients. Oncology 60:134-140, 2001
15. Freilich RJ, Delattre J-Y, Monjour A, et al: Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 46:435-439, 1996
16. Herrlinger U, Kuker W, Platten M, et al: First-line therapy with temozolomide induces regression of primary CNS lymphoma. Neurology 58:1573-1574, 2002
17. Soussain C, Suzan F, Hoang-Xuan K, et al: Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 19:742-749, 2001
18. Abrey LE, Moskowitz CH, Mason WP: Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem cell rescue in patients with newly diagnosed primary CNS lymphoma: Intent to treat analysis. J Clin Oncol 21:4151-4156, 2003
19. Bessell EM, Lopez-Guillermo A, Villa S, et al: Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: An analysis of the CHOD/BV AM regimen followed by two different radiotherapy treatments. J Clin Oncol 20:231-236, 2002